1. Articles in category: Other Business News

    985-1008 of 1190 « 1 2 ... 39 40 41 42 43 44 45 ... 48 49 50 »
    1. The UK Fights Back

      The UK Fights Back
      In tough economic times, government continues to support innovation in optics. The UK economy has had a tough slog in the past year and a half. At the end of September, the government reported that the gross domestic product shrank by 0.6% in the April to June period, marking five consecutive quarters of contraction. The 5.7% drop in that time doubles that seen during the recession of the early 1990s, and even approaches the 6.4% contraction witnessed in 1980-81. There are signs of improvement. The government predicts growth in the July to September period, and possibly even ...
      Read Full Article
    2. Hybrid photodiodes promise cost-effective short-wave IR imaging

      Hybrid photodiodes promise cost-effective short-wave IR imaging
      A combination of organic and inorganic nanoscale materials, along with solution processing, enables a tunable imager for short-wave infrared imaging. The growing interest in short-wavelength infrared (SWIR) imagers is related to the increasing number of applications in this particular spectral region. Wavelengths between the silicon bandgap limit of about 1.1 and 2 µm are of commercial interest because of the low water absorption in this spectral region. Photodiodes for the SWIR are usually made
      Read Full Article
    3. Volcano Corporation Presentation at Piper Jaffray Conference to be Webcast

      SAN DIEGO, Nov 24, 2009 /PRNewswire-FirstCall via COMTEX/ ----Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the 21st Annual Piper Jaffray Health Care Conference on Tuesday, December 1. The presentation by Scott Huennekens, president and chief executive officer, will begin at 11 a.m., Eastern Standard Time (8 a.m., Pacific Standard Time). The presentation will be available through the conference website at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=VOLC&item_id=2539149 and ...
      Read Full Article
    4. High Speed Imager

      High Speed Imager
      Michelson Diagnostics (MDL) has announced new high speed imaging capability for its EX1301 OCT Microscope. OCT (Optical Coherence Tomography) images can be captured at up to 40 frames per second, enabling imaging of dynamic processes such as the heartbeat of a fruit-fly. “We believe that this capability will prove very useful for biologists, for example those who are researching the genetic origins of heart disease”, said Jon Holmes, MDL’s CEO, “The high frame rate, coupled with market-leading optical resolution from our patented Multi-Beam OCT optics, in an off-the-shelf package, will open up new opportunities for the developmental biology scientist ...
      Read Full Article
    5. Michelson Diagnostics Enters Into Exclusive Distribution Contract with Integral Corporation in Japan

      Michelson Diagnostics Enters Into Exclusive Distribution Contract with Integral Corporation in Japan
      (Orpington, UK) November 12, 2009 – Michelson Diagnostics has appointed Integral Corporation, a distributor of analytical equipment to the healthcare and cosmetics industry, as exclusive distributor for its VivoSight scanner in Japan. Michelson Diagnostics is a leading innovator in Multi-Beam Optical Coherence Tomography (OCT) products for scientific research and healthcare imaging. Under the terms of the agreement Integral Corporation will exclusively market and sell the VivoSight scanner for non-clinical use in cosmetic research settings. Integral has also purchased a VivoSight system for use in customer demonstrations that will begin in November. The agreement is the latest milestone Michelson Diagnostics has achieved ...
      Read Full Article
    6. Imalux Corporation - Medical Equipment - Deals and Alliances Profile - new report released

      Imalux Corporation (Imalux) is engaged in the development, manufacture and marketing of imaging systems for the diagnostic markets. Its products are developed using its Optical Coherence Tomography (OCT) technology and are used in urology, gastroenterology, gynecology, dermatology, dentistry and ENT applications. The company is headquartered in Ohio, United States. The company’s major product Niris Imaging System is an imaging tool used in the evaluation of human tissue microstructure and provides two-dimensional, cross-sectional, real-time depth visualization of normal and abnormal tissue microstructures.
      Read Full Article
      Mentions: Imalux Imalux Niris
    7. Volcano Reports 22 Percent Increase in Third Quarter Revenues

      Volcano Reports 22 Percent Increase in Third Quarter Revenues
      Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today reported revenues of $53.9 million for the third quarter of fiscal 2009. The results for the quarter ended September 30, 2009, represent an increase of 22 percent over revenues of $44.1 million in the third quarter of 2008. Revenues for the third quarter of 2009 include $4.6 million from Axsun Technologies, Inc., which Volcano acquired at the end of 2008, and for which the company recorded no revenues in the third ...
      Read Full Article
    8. Volcano Posts Q3 Loss; Backs FY09 View; Makes $11M milestone payment to Cardiospectra

      Volcano Corporation (VOLC: News ) reported a third-quarter GAAP net loss of $4.0 million or $0.08 per share, compared with a GAAP net income of $744 thousand or $0.01 per share in the year-ago quarter. Non-GAAP net income, which excludes stock-based compensation expense of $2.6 million and commissions of $1.4 million, was $7 thousand or $0.00 per share. This compares with the year-ago non-GAAP net income of $3.3 million or $0.06 per share, excluding stock-based compensation expense of $2.5 million. On average, ten analysts polled by Thomson Reuters expected the company to ...
      Read Full Article
    9. Volcano Reports 22 Percent Increase in Third Quarter Revenues

      Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today reported revenues of $53.9 million for the third quarter of fiscal 2009. The results for the quarter ended September 30, 2009, represent an increase of 22 percent over revenues of $44.1 million in the third quarter of 2008. Revenues for the third quarter of 2009 include $4.6 million from Axsun Technologies, Inc., which Volcano acquired at the end of 2008, and for which the company recorded no revenues in the third ...
      Read Full Article
    10. Atrium Medical Corporation Announces Release of the Final Results of the "coctail Study"

      HUDSON, NH--(Marketwire - November 5, 2009) - Atrium Medical Corporation is proud to announce the release of the final results of the "COCTAIL Study," a clinical study comparing local administration of an anti-platelet medication with the company's proprietary infusion balloon technology. Dr. Francesco Prati of San Giovanni Hospital and the European Imaging Laboratory in Rome, Italy presented the results of this study at the recent TCT (Transcatheter Cardiovascular Therapeutics) meeting held in San Francisco, California. The final results demonstrated that super selective local intracoronary infusion of an anti-platelet medication known as abciximab* through the Atrium® ClearWay™ RX Local Therapeutic Infusion ...
      Read Full Article
    11. Avo Photonics and Case Western Reserve University Are Pleased to Announce the Completion of a Design and Development Contract for an Optical Coherence Tomography (OCT) Forward Imaging Catheter

      Avo Photonics and Case Western Reserve University Are Pleased to Announce the Completion of a Design and Development Contract for an Optical Coherence Tomography (OCT) Forward Imaging Catheter
      HORSHAM, Pa.--(BUSINESS WIRE)--Nearly 4 million people nationwide suffer from cardiac arrhythmias each year, according to the 2006 U.S. Cardiac Rhythm Management Market report by Frost and Sullivan. About 2.5 million of these cases cannot be treated or controlled through medication alone. Since pharmacological therapies have limited effectiveness, radiofrequency (RF) catheter ablation has emerged as the prominent approach for treating a broad range of arrhythmias. However, during the procedure physicians have no direct visualization of intra-cardiac structures, nor do they have a means to measure successful lesions. Recognizing this problem, researchers at Case Western Reserve University began ...
      Read Full Article
    12. Ellex unveils latest generation of its diagnostic ultrasound system

      San Francisco—Ellex Medical Lasers Ltd.unveiled the latest version of its diagnostic ultrasound system (Eye Cubed) at the recent annual meeting of the American Academy of Ophthalmology. The new generation of the deviceincludes a software interface that is designed to be intuitive and coordinate with Windows-based operation, expanded measurement options via uniquely shaped calipers,and improved export and import functions, according to the company. Also, new, customized A-Scan and B-Scan modeswere designed with retinal sub-specialists and anterior-segment surgeons in mind, and the device includes an A-scan feature for cataract surgeons that eliminates corneal compression and transmits ultrasound waves through ...
      Read Full Article
    13. Enrollment Begins for Stentys’ Apposition II

      December 4, 2009—Stentys, Inc. (Princeton, NJ) announced the commencement of enrollment in the APPOSITION II clinical study, which is a randomized trial comparing the Stentys self-expanding stent with a conventional balloon-expandable stent in acute myocardial infarction (AMI) patients. The study’s primary endpoint is stent strut apposition at day 3 postprocedure via extremely high-resolution optical coherence tomography (OCT) imaging. Stefan Verheye, MD, PhD, is principal investigator of APPOSTION II, and Professor Christian Spaulding, MD, PhD, enrolled the study’s first patient at the Cochin Hospital, Descartes University in Paris.
      Read Full Article
    14. Nidek RS-3000 OCT/SLO System Brochure

      Nidek RS-3000 OCT/SLO System Brochure
      NIDEK is proud to announce its first release of advanced spectral domain OCT/confocal ophthalmoscope system, RS-3000 OCT "RetinaScan". The RS-3000 is the high-speed spectral domain OCT with the tradition of NIDEK, advanced auto-focus/auto Z alignment technology offers the combination of Precision and Ease-of-Use. Max. 50 image averaging 53, 000, 25, 000~27, 000 512 Conventional SD - OCT Time Domain - OCT A-scans / sec. 53,000 A-scans / sec. greatly helps to reduce the measurement time and minimize artifacts. The advanced speckle-noise-reduction system by averaging images provides 4 micron OCT digital resolution. Highresolution image shows the discrete retinal layers.
      Read Full Article
      Mentions: Nidek Nidek RS-3000
    15. Nidek RS-3000 OCT/SLO System

      Nidek RS-3000 OCT/SLO System
      Nidek Advanced OCT / SLO System RS-300. Reducing the measurement time and minimizing artifacts with high-speed scan (53,000 A scan/Sec) Providing high-quality image (4 micron OCT digital resolution) with advanced speckle-noise-reduction system. The availability of the products differs from country to country depending on the status of approval in each country. Specifications and design are subject to change. Fast and simple operation with optimization
      Read Full Article
    16. Volcano Corporation Schedules Third Quarter Conference Call, Webcast

      SAN DIEGO, Oct. 26 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today announced that it will report its operating results for the third quarter and first nine months of fiscal 2009 on Thursday, November 5. The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 2 p.m., Pacific Standard Time (5 p.m., Eastern Standard Time), Thursday, November 5, hosted by Scott Huennekens, president and chief executive officer, and ...
      Read Full Article
    17. Canon U.S.A. Showcases The CX-1 Mydriatic/Non-Mydriatic Hybrid Digital Retinal Camera at the American Academy of Ophthalmology’s Annual Meeting in San Francisco

      SAN FRANCISCO--(BUSINESS WIRE)--At the American Academy of Ophthalmology’s (AAO) Annual Meeting, Canon U.S.A., Inc., a leader in medical imaging, will shine the spotlight on the latest addition to its complete line of total digital imaging and workflow management solutions for eyecare professionals, the CX-1 Mydriatic/Non-Mydriatic Hybrid Digital Retinal Camera1, in the North Hall, booth #3048 at the Moscone Center in San Francisco (October 24th – 27th). The CX-1 is the Company’s first fully hybrid digital retinal camera with both mydriatic and non-mydriatic modes. With one-touch, the operator can automatically switch between mydriatic and non-mydriatic ...
      Read Full Article
    18. Case Western Reserve University, University Hospitals Case Medical Center and Bioptigen Establish Exclusive Licensing Agreement

      Case Western Reserve University, University Hospitals Case Medical Center and Bioptigen Establish Exclusive Licensing Agreement
      Case Western Reserve University, University Hospitals Case Medical Center and Bioptigen Establish Exclusive Licensing Agreement Technology Helps Doctors and Researchers Diagnose and Seek Cures for Eye Diseases. CLEVELAND and RESEARCH TRIANGLE PARK, N.C. – Case Western Reserve University and University Hospitals Case Medical Center have granted to Bioptigen, of Research Triangle Park, N.C ., an exclusive intellectual property licensing agreement for Fourier domain optical coherence tomography (FDOCT), an imaging technology developed from research at the university’s Department of Biomedical Engineering. Advances in functional FDOCT are expected to enhance the early diagnosis and treatment of eye diseases, most notably diabetic ...
      Read Full Article
    19. Volcano Corporation Presentation at Biocom Investor Conference to Be Webcast

      SAN DIEGO, Oct. 21 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it will be participating in the BIOCOM Investor Conference on Monday, October 26. The presentation by Scott Huennekens, president and chief executive officer, will begin at 4:30 p.m., Pacific Daylight Time (7:30 p.m., Eastern Daylight Time). The presentation will be available through the conference website at http://cc.talkpoint.com/bcom001/102609a_me/?entity=4_MFEJRB8 and via the company's website at www.volcanocorp ...
      Read Full Article
    20. Carl Zeiss Meditec launches website called "Eye on OCT"

      Carl Zeiss Meditec launches website called "Eye on OCT"
      Dear OCT News Subscriber Carl Zeiss Meditec has recently launched a website called "Eye on OCT" (www.oct.zeiss.com). "Eye on OCT" is focused exclusively on news and education about Optical Coherence Tomography technology and clinical application for ophthalmologists, optometrists, and other eye care professionals. While there is some overlap with "OCT News", "Eye on OCT" is specifically tailored to eye care with additional sources of unique and original information including: A Physician Spotlight, OCT Image Gallery, Case Reports, Clinician Experience, Presentation Library, News Articles, and a broader range of OCT ophthalmic Journal Articles. If you are primarily interested ...
      Read Full Article
    21. Underskin cancer detection is not for the faint hearted

      When Sira Technology, the company that Jon Holmes worked for, was brought down by the deficit in its final salary pension scheme, he was given 20 minutes to clear his desk. When Sira Technology, the company that Jon Holmes worked for, was brought down by the deficit in its final salary pension scheme, he was given 20 minutes to clear his desk. Sira was mainly known for industrial instruments, but Mr Holmes, a Cambridge physics graduate, and his team had been exploring ways to exploit the company's technology and expertise in bio-medical applications. In particular, they had made great ...
      Read Full Article
    22. Start-ups: is it time for something new?

      Start-ups: is it time for something new?
      With the global economy in the dumps, this looks like no time to be starting a new photonics business. But even now, argues David Nugent of Elucidare, determined innovators can still connect with capital. David NugentElucidare of Cambridge, UK, is a boutique investment advisory and business development consultancy that specializes in photonics, semiconductors, medical imaging, renewable energy and pharmaceuticals. With clients spanning the investment spectrum – from university technology-transfer units to institutional fund managers – Elucidare has helped more than 250 companies create intellectual property, raise investment funds, and exit through trade sale or initial public offering (IPO).
      Read Full Article
    23. Carl Zeiss Meditec Launches "Eye On OCT"

      Carl Zeiss Meditec Launches "Eye On OCT"
      DUBLIN, CA--(Marketwire - October 6, 2009) - A new online optical coherence tomography (OCT) resource for the eye care industry was launched by Carl Zeiss Meditec during the Retina Congress 2009 convention in New York City this past weekend. Eye On OCT (www.oct.zeiss.com) is the most extensive resource for news and education about OCT technology and clinical application for ophthalmologists, optometrists and other eye care professionals. "Eye On OCT is the first and only site of its kind for the eye care industry," said Eric Swanson, founder of OCTnews.org and co-author of the first OCT clinical paper ...
      Read Full Article
    985-1008 of 1190 « 1 2 ... 39 40 41 42 43 44 45 ... 48 49 50 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. OCT Companies in the News

    1. (2 articles) PhotoniCare
    2. (1 articles) Cylite
    3. (1 articles) Canon Medical Systems
    4. (1 articles) Carl Zeiss Meditec
    5. (1 articles) Perimeter Medical Imaging